High‐dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma

Cell Transplantation ◽

High Dose ◽

Consolidation Treatment ◽

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

Leukemia Research ◽

10.1016/j.leukres.2006.09.021 ◽

2007 ◽

Vol 31 (8) ◽

pp. 1069-1075 ◽

Cited By ~ 18

Author(s):

Don M. Benson ◽

Patrick J. Elder ◽

Thomas S. Lin ◽

William Blum ◽

Sam Penza ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma

Bone Marrow Transplantation ◽

10.1038/s41409-019-0534-0 ◽

2019 ◽

Vol 54 (11) ◽

pp. 1881-1891

Author(s):

Noa Biran ◽

Scott D. Rowley ◽

David H. Vesole ◽

Shijia Zhang ◽

Michele L. Donato ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Cell Transplantation ◽

Conditioning Regimen ◽

High Dose ◽

Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1783448 ◽

2020 ◽

Vol 61 (11) ◽

pp. 2714-2721

Author(s):

Ga-Young Song ◽

Sung-Hoon Jung ◽

Je-Jung Lee ◽

Jin Seok Kim ◽

Chang-Ki Min ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Propensity Score ◽

Cell Transplantation ◽

Conditioning Regimen ◽

High Dose ◽

High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem cell transplantation in multiple myeloma

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1703013 ◽

2001 ◽

Vol 27 (9) ◽

pp. 925-931 ◽

Cited By ~ 16

Author(s):

PC Huijgens ◽

HM Dekker-van Roessel ◽

AR Jonkhoff ◽

GC Admiraal ◽

S Zweegman ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Whole Blood ◽

High Dose ◽

Cell Harvesting ◽

High-dose melphalan on day 2 versus 1 before autologous stem cell transplantation for multiple myeloma.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.6545 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 6545-6545

Author(s):

K. Rakszawski ◽

J. J. Drabick ◽

N. G. Dolloff ◽

J. M. Sivik ◽

J. Malysz ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

Targeted radiotherapy delivered by an yttrium-90 radio-labelled Anti-CD66 monoclonal antibody with high dose melphalan compared to melphalan alone, prior to autologous stem cell transplantation for multiple myeloma

http://isrctn.org/> ◽

10.1186/isrctn11933044 ◽

2012 ◽

Author(s):

Kim Orchard

Keyword(s):

Multiple Myeloma ◽

Monoclonal Antibody ◽

Stem Cell ◽

Cell Transplantation ◽

High Dose ◽

Targeted Radiotherapy ◽

High Dose Melphalan ◽

Yttrium 90

Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy

International Journal of Hematology ◽

10.1007/s12185-013-1311-2 ◽

2013 ◽

Vol 97 (5) ◽

pp. 634-639 ◽

Cited By ~ 1

Author(s):

Bo-Hee Lee ◽

Seung Hwan Shin ◽

Chang-Ki Min ◽

Ho-Young Yhim ◽

Jae-Yong Kwak ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Induction Therapy ◽

High Dose ◽

High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1705925 ◽

2007 ◽

Vol 41 (6) ◽

pp. 547-554 ◽

Cited By ~ 6

Author(s):

C Papadimitriou ◽

U Dafni ◽

A Anagnostopoulos ◽

G Vlachos ◽

Z Voulgaris ◽

...

Keyword(s):

Ovarian Cancer ◽

Stem Cell ◽

Randomized Trial ◽

Cell Transplantation ◽

High Dose ◽

Single Institution ◽

Consolidation Treatment ◽

Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma

Journal of Chemotherapy ◽

10.1179/1973947812y.0000000004 ◽

2012 ◽

Vol 24 (3) ◽

pp. 167-172 ◽

Cited By ~ 5

Author(s):

Muneer H Abidi ◽

Zartash Gul ◽

Judith Abrams ◽

Lois Ayash ◽

Abhinav Deol ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Cell Transplantation ◽

Phase I Trial ◽

Maintenance Phase ◽

High Dose ◽

Glutamine supplementation to reduce oral mucositis in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation: A feasibility study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2005.11.441 ◽

2006 ◽

Vol 12 (2) ◽

pp. 144 ◽

Cited By ~ 1

Author(s):

L.K. Hansen ◽

P.A. Smythe ◽

K.S. Hansen ◽

D.R. Gruenberg ◽

D. Callaway

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Feasibility Study ◽

Oral Mucositis ◽

Glutamine Supplementation ◽

High Dose ◽